A fabulous narrative of twists and turns and collaborations across multiple nonprofit institutions, companies, governments. As we debate drug pricing and R/D timelines, often cynically, this is a nice example of staying focused on the problem and bringing assets together for a solution. Well done! Great read to start 2020.